Clofarabine and Low-dose Cytarabine Followed by Consolidation Therapy in AML Patients Age Greater Than or Equal to 60 Years
Clinical trial NCT01193400 · TERMINATED
Trial details
- NCT number
- NCT01193400
- Sponsor
- PETHEMA Foundation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-02-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.